TECVAYLI® monotherapy demonstrates superior progression-free and overall survival versus standard of care as early as first relapse in patients with multiple myeloma ...

Johnson & Johnson (NYSE:JNJ), a worldwide leader in multiple myeloma therapies, today announced positive topline results from the investigational Phase 3 MajesTEC-9 study of TECVAYLI® ...
pharmaphorum

Leveraging AI agents to eliminate ‘white space’ in clinical trials

For decades, clinical trials have played an integral role in developing and determining the safety and efficacy of new and often lifesaving drugs. However, the clinical trial process has become ...
Nature

Advances in electron microscopy drive diverse scientific fields

Nearly a century ago, Ernst Ruska and Max Knoll provided the first demonstration of a microscope that could image specimens using electrons rather than light. The earliest images obtained via this ...